RT Journal Article
SR Electronic
T1 Bioresorbable stents: The future of interventional cardiology?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S18
OP S23
DO 10.3949/ccjm.83.s2.03
VO 83
IS 11 suppl 2
A1 Stephen G. Ellis
A1 Haris Riaz
YR 2016
UL http://www.ccjm.org/content/83/11_suppl_2/S18.abstract
AB The introduction of stents has drastically reduced target-lesion restenosis rates associated with percutaneous coronary angioplasty. Bare-metal stents were the first introduced, followed by drug-eluting stents, both of which had significant impacts on the complication rates. Stents, however, have resulted in the emergence of stent thrombosis and stent restenosis, which can cause life-threatening cardiac complications. Three new technological approaches are being investigated to overcome these complications: stents coated with bioresorbable polymers, stents without polymers, and completely bioresorbable stents. Initial results are encouraging, but more data are needed to ascertain their implications for clinical practice.